TITLE

Sigma-Aldrich Bolsters LatAm Exposure

AUTHOR(S)
Cody, Tamika
PUB. DATE
May 2011
SOURCE
Mergers & Acquisitions Report;5/30/2011, Vol. 24 Issue 22, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the acquisition of Brazilian-based business Vetec Quimica Fina Ltda. by life science and high technology company Sigma-Aldrich Corporation. According to Sigma-Aldrich vice president and managing director Eric Green, the acquisition is part of Aldrich's strategy to build presence in the emerging markets. The article sees the acquisition broadening Aldrich's distribution channel.
ACCESSION #
61045947

 

Related Articles

  • Sigma-Aldrich completes acquisition of BioReliance.  // BioSpectrum;Mar2012, Vol. 10 Issue 3, p73 

    The article reports on the completions of the acquisition of the biopharmaceutical testing services provider BioReliance Holdings Corp. by Sigma-Aldrich Corp. in India.

  • Sigma-Aldrich Sells Its B-Line Systems To Cooper Industries. Papanikolaw, Jim // Chemical Market Reporter;04/03/2000, Vol. 257 Issue 14, p3 

    Reports the acquisition of the B-Line Systems business of Cooper Industries Inc. by Sigma-Aldrich Corp. Value of the deal; Main products of B-Line Systems; 1999 revenue of Cooper Industries.

  • Trinity to Buy Sigma's Coagulants.  // Chemical Week;7/3/2002, Vol. 164 Issue 27, p73 

    Reports on the acquisition of the coagulants product division of Sigma Aldrich by Trinity Biotech. Revenue generated by the unit for Sigma.

  • Sigma-Aldrich Acquires BioReliance for $350.  // India -- West;2/10/2012, Vol. 37 Issue 12, pB4 

    The article reports on the move of Sigma-Aldrich Corp. which acquired BioReliance Holdings Inc. for 350 million dollars from Avista Capital Partners.

  • Completed Aquisition.  // Pharmaceutical Technology;May2005, Vol. 29 Issue 5, p82 

    This article reports that Sigma-Aldrich Corp. has completed its acquisition of the ProMgo Group from Degussa AG. Terms of the proposed purchase were not disclosed. Proligo had 2004 sales of approximately $40 million. Nine months of Proligo's 2005 operating results will be added to...

  • in brief.  // Pharmaceutical Technology Europe;Sep2004, Vol. 16 Issue 9, p10 

    This article briefly reports various recent news items from the field of pharmaceutical industry. Recently, Sigma-Aldrich Corp. has announced that it has expanded its fine chemicals capabilities to better serve pharmaceutical manufacturers through its acquisition of another pharmaceutical...

  • Biochemical specialist sold to Mo. firm. SODER, CHUCK // Crain's Cleveland Business;4/16/2012, Vol. 33 Issue 16, p0010 

    The article reports on the move of Rob and Fred Sternfeld, owner of the Research Organics Inc., which sold the company to Sigma-Aldrich Corp. of St. Louis, Michigan. According to Gilles Cottier, executive vice president at Sigma, the acquired company's quality systems and its manufacturing...

  • Increased Chilean presence for Sigma-Aldrich.  // Medical Device Daily;3/17/2009, Vol. 13 Issue 50, p8 

    The article reports on the acquisition of Sigal Ltda by Sigma-Aldrich in an effort to expand its presence in the research and manufacturing sector in Chile. The acquisition allowed Sigma-Aldrich to form Sigma-Aldrich Quimica Ltda, designed to offer a foundation for the company's future growth in...

  • Sigma-Aldrich buys Pharmorphix.  // LC-GC North America;Sep2006, Vol. 24 Issue 9, p968 

    The article reports on the acquisition of Cambridge, England-based research company Pharmorphix Ltd. by St. Louis, Missouri-based pharmaceutical industry Sigma-Aldrich Corp. The addition of Pharmorphix will broaden the manufacturing services customer base of Sigma-Aldrich, and will enhance...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics